Brink Therapeutics
Next-Generation Enzymes Therapy Development
- B2B
About Brink Therapeutics
Developing ultra-precise enzymes, surpassing CRISPR-Cas9, to revolutionize Cell and Gene therapies, enabling large-scale production for cancer, genetic disorders, and other diseases.
Key facts
- Industry
- Biotechnology Research
- Company size
- 11–50 employees
- Headquarters
- Paris, Grand Est, France
- Founded
- 2024
- Revenue
- Early-stage startupno revenue figure
- Website
- brinktx.com
- linkedin.com/company/brinktx
Brink Therapeutics at a glance
Brink Therapeutics is a B2B company in the Biotechnology Research industry, headquartered in Paris, Grand Est, France.
Brink Therapeutics was founded in 2024.
Brink Therapeutics has 11–50 employees.
Selling to companies like Brink Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies